Join us on June 13th for the ‘Supporting Biomedical Innovation Through the NIH SBIR/STTR Programs’ event to unlock access to over $1.2B in early-stage funding from the National Institutes of Health.
Join our newsletter and find the invention that is a perfect match for your company. We will notify you of new technologies before publishing them on the website.
Devices and methods for peripheral nerve stimulation with an electrode assembly having a lead body with a tapered transition, at least one anchor, and at least one distal lead configured to connect to the lead body are disclosed.
“The present disclosure provides methods of inhibiting PARG in cancer cells, including methods comprising administering a PARG inhibitor that modulates position Tyr795 in PARG. Also provided herein are methods of treating and/or preventing cancer comprising administering a PARG inhibitor. In some embodiments, the PARG inhibitors are of the formula: wherein the variables are defined herein.
The present disclosure provides compositions and methods for selectively killing cancer cells, wherein the composition comprises a compound of Formula (I). The selective killing of cancer cells occurs with an improved potency and safety profile compared to similar compounds. In particular, the compositions and methods of the invention show reduced platelet toxicity and retained or improved toxicity in cancer cells.
BioVentures was established as a formal outgrowth of the University of Arkansas for Medical Sciences‘ (UAMS) interest in promoting a biomedical technology industry for Arkansas and translating its research into products that benefit human health.
UAMS established BioVentures to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the development of startup companies that are based on technology developed at UAMS, and contributions to Arkansas’ economic development.
BioVentures links the research minds at UAMS to global markets in order to advance Arkansas’ scientific and economic development.
Are you a biomedical entrepreneur or small business in need of resources to accelerate your innovation? If the answer is yes, you’re in luck! The
BioVentures implements a new software platform to optimize its technology transfer operations, improve the invention disclosure process, and offer better data transparency and tracking capabilities for inventors.
Four Health Sciences Innovation and Entrepreneurship Fellows from the University of Arkansas won second place overall and third in the elevator pitch in the Stu Clark New Venture Championships at the University of Manitoba. The competition, focused on entrepreneurship and innovation, had over $60,000 in cash prizes and allowed participants to connect with other entrepreneurs, investors, and business leaders from their industrie
401 South Cedar Street Little Rock, Arkansas 72205
(501) 686-6696
bioventures@uams.edu